Pfizer Inc. YUANTA DR (PFIZER19) Stock Price & News

All values in SGD	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	636,33 m	636,33 m	677,34 m	677,34 m
Cost of goods sold	457,43 m	457,43 m	489,02 m	489,02 m
Cost of revenue	457,43 m	457,43 m	489,02 m	489,02 m
Research and development expenses	5,34 m	5,34 m	6,55 m	6,55 m
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	81,62 m	81,62 m	82,66 m	82,66 m
Operating expense	116,86 m	116,86 m	120,35 m	120,35 m
Total operating expenses	574,29 m	574,29 m	609,37 m	609,37 m
Operating income	62,03 m	62,03 m	67,97 m	67,97 m
Other non operating income	465,00 k	465,00 k	346,00 k	346,00 k
EBT including unusual items	71,57 m	71,57 m	74,92 m	74,92 m
EBT excluding unusual items	71,57 m	71,57 m	74,92 m	74,92 m
Income tax expense	14,41 m	14,41 m	15,13 m	15,13 m
Effective tax rate	20,13%	20,13%	20,19%	20,19%
Other operating expenses	21,35 m	21,35 m	22,28 m	22,28 m
Net income	56,99 m	56,99 m	59,65 m	59,65 m
Net profit margin	8,96%	8,96%	8,81%	8,81%
Earnings per share	-	-	-	-
Interest and investment income	9,08 m	9,08 m	6,60 m	6,60 m
Interest expense	-220,00 k	-220,00 k	-172,50 k	-172,50 k
Net interest expenses	8,86 m	8,86 m	6,43 m	6,43 m
Depreciation and amortization charges	8,56 m	8,56 m	8,86 m	8,86 m
EBITDA	67,43 m	67,43 m	73,80 m	73,80 m
Gain or loss from assets sale	-15,00 k	-15,00 k	-	-

Finance